Pub. L. 116-136, div. A, tit. III, subtit. F, pt. II, sec. 3861 (as amended)

FINDING.

Year: 2025Length: 103 wordsOfficial source
SEC. 3861. [21 U.S.C. 379j-71 note] FINDING. The Congress finds that the fees authorized by the amendments made in this part will be dedicated to OTC monograph drug activities, as set forth in the goals identified for purposes of part 10 of subchapter C of chapter VII of the Federal Food, Drug, and Cosmetic Act, in the letters from the Secretary of Health and Human Services to the Chairman of the Committee on Health, Education, Labor, and Pensions of the Senate and the Chairman of the Committee on Energy and Commerce of the House of Representatives, as set forth in the Congressional Record.
Cross-references to the US Code
21 U.S.C. 379j-71 note
Pub. L. 116-136, div. A, tit. III, subtit. F, pt. II, sec. 3861 (as amended): FINDING. | Justis AI